Skip to main content
. 2009 Nov 16;10:117. doi: 10.1186/1471-2350-10-117

Table 1.

Characteristics of the Study Population.

Cases (%) Controls (%)
Gender
Male 463 (58%) 423 (53%)
Female 334 (42%) 370 (47%)

Age group (years)
20-49 150 (19%) 208 (26%)
50-59 194 (24%) 169 (21%)
60-69 214 (27%) 206 (26%)
70+ 239 (30%) 210 (26%)

Ethnicity
Caucasian 625 (78%) 613 (77%)
Asian 80 (10%) 90 (11%)
South Asian 29 (4%) 37 (5%)
Mixed/Other 36 (5%) 34 (4%)
Unknown/Refused 27 (3%) 19 (2%)

Pathology
B-cell lymphomas
DLBCL 210 (26%) -
FL1 138 (17%) -
FL2/FL3 78 (10%) -
MZL/MALT 92 (12%) -
MCL 47 (6%) -
SLL/CLL 43 (5%) -
LPL 42 (5%) -
MISC BCL 71 (9%) -
T-cell lymphomas
MF 40 (5%) -
PTCL 29 (4%) -
MISC TCL 7 (1%) -

Total 797 (100%) 793 (100%)

DLBCL = Diffuse Large B-Cell Lymphoma, FL = Follicular Lymphoma, FL1 = Follicular Lymphoma grade 1, FL2 = Follicular Lymphoma grade 2, FL3 = Follicular Lymphoma grade 3, MZ/MALT = Marginal Zone lymphoma/Mucosa-Associated Lymphoma Tissue lymphoma, MCL = Mantle Cell lymphoma, SLL = Small Lymphocytic Lymphoma, LPL = Lymphoplasmacytic Lymphoma, Misc. B-cell = Miscellaneous B-cell lymphoma, MF = Mycosis Fungoides, PTCL = Peripheral T-Cell Lymphoma, Misc. T-cell = Miscellaneous T-cell lymphoma.